| Title |
Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to sacituzumab govitecan in triple-negative breast cancer
|
|---|---|
| Published in |
Cancer Discovery, August 2021
|
| DOI | 10.1158/2159-8290.cd-21-0702 |
| Pubmed ID | |
| Authors |
James T. Coates, Sheng Sun, Ignaty Leshchiner, Nayana Thimmiah, Elizabeth E. Martin, Daniel McLoughlin, Brian P. Danysh, Kara Slowik, Raquel A. Jacobs, Kahn Rhrissorrakrai, Filippo Utro, Chaya Levovitz, Elyssa Denault, Charlotte S. Walmsley, Avinash Kambadakone, James R. Stone, Steven J. Isakoff, Laxmi Parida, Dejan Juric, Gad Getz, Aditya Bardia, Leif W. Ellisen |
X Demographics
The data shown below were collected from the profiles of 100 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 37 | 37% |
| Italy | 5 | 5% |
| France | 4 | 4% |
| Canada | 3 | 3% |
| United Kingdom | 3 | 3% |
| Japan | 2 | 2% |
| Belgium | 2 | 2% |
| Egypt | 1 | 1% |
| Australia | 1 | 1% |
| Other | 2 | 2% |
| Unknown | 40 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 51 | 51% |
| Scientists | 31 | 31% |
| Practitioners (doctors, other healthcare professionals) | 12 | 12% |
| Science communicators (journalists, bloggers, editors) | 6 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 74 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 13 | 18% |
| Student > Ph. D. Student | 11 | 15% |
| Student > Postgraduate | 5 | 7% |
| Student > Doctoral Student | 5 | 7% |
| Other | 4 | 5% |
| Other | 4 | 5% |
| Unknown | 32 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 20% |
| Biochemistry, Genetics and Molecular Biology | 11 | 15% |
| Immunology and Microbiology | 4 | 5% |
| Agricultural and Biological Sciences | 2 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 1% |
| Other | 6 | 8% |
| Unknown | 35 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 121. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 October 2023.
All research outputs
#352,031
of 25,698,912 outputs
Outputs from Cancer Discovery
#173
of 4,147 outputs
Outputs of similar age
#9,215
of 438,467 outputs
Outputs of similar age from Cancer Discovery
#10
of 85 outputs
Altmetric has tracked 25,698,912 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,147 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.2. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,467 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.